glycovax

Patent vaccine breast cancers - Brevet vaccin cancers du sein

Glycovax Pharma Files a Patent Application for a New Semi-Synthetic Vaccine against Breast Cancers

Glycovax Pharma Files a Patent Application for a New Semi-Synthetic Vaccine against Breast Cancers MONTREAL, April 4, 2018 – Glycovax Pharma Inc. (“Glycovax” or “the Company”), a leader in the development of new therapeutic strategies against cancer and infectious diseases, announced today that it has filed a patent application with the United States Patent and Trademark Office, entitled “Precision …

Glycovax Pharma Files a Patent Application for a New Semi-Synthetic Vaccine against Breast Cancers Read More »